SLAM family member 7

BE0003492ProteinHumansSLAMF7

Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. It is acted on by 2 drugs in DrugBank.

Gene name
SLAMF7
UniProtKB entry
Q9NQ25Swiss-Prot
Cellular location
Membrane
Residues / weight
335 residues · 37,421 Da
Also known as
CD2 subset 1 · CD2-like receptor-activating cytotoxic cells · CRACC · CS1 · Membrane protein FOAP-12

Resolves to

Protein
UniProtQ9NQ25UniProt nameSLAF7_HUMAN
Gene
HGNCHGNC:21394NCBI Gene57823GeneCardsSLAMF7
Pharmacology
IUPHAR/GtoPdb2850KEGGhsa:57823
Drugs

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
5Clinical trialsTrials of drugs acting on it, by phase and status
Sign in
4GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
18+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on SLAM family member 7, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In